Deciphera Pharmaceuticals, Inc. Additional Paid in Capital

Deciphera Pharmaceuticals, Inc. Additional Paid in Capital

Deciphera Pharmaceuticals, Inc. had Additional Paid in Capital of $569.71 million as of 2018-06-30, per its 10-Q filed 2018-08-07.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital

us-gaap:AdditionalPaidInCapital · last filed 2018-08-07

• 2018-06-30: Additional Paid in Capital $569.71M.
• 2018-03-31: Additional Paid in Capital $381.56M.
• 2017-12-31: Additional Paid in Capital $379.52M.
• 2016-12-31: Additional Paid in Capital $5.83M.